Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
72599-27-0
Purity
95%
Miglustat is an inhibitor of glucosylceramide synthase. It is used for the management of mild to moderate type I Gaucher disease for patients who are not candidates for whole enzyme replacement.
Properties
Name
Miglustat
Smiles
CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Targets
Please log in to see this information
1,5-(butylimino)-1,5-dideoxy-D-glucitol | Miglustat | N-Butyl-1-deoxynojirimycin | N-butyl 1,5-dideoxy-1,5-imino-D-glucitol | N-butyl-deoxygalactonojirimycin | N-butyldeoxynojirimycin | NB-DNJ | zavesca
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$148
2 mg
$177
5 mg
$320
10 mg
$527
15 mg
$655
20 mg
$741
25 mg
$878
30 mg
$1009
35 mg
$1171
40 mg
$1299
45 mg
$1430
50 mg
$1527
75 mg
$1912
100 mg
$2352
Quantity
1
Total amount
$ 320
1,5-(butylimino)-1,5-dideoxy-D-glucitol | Miglustat | N-Butyl-1-deoxynojirimycin | N-butyl 1,5-dideoxy-1,5-imino-D-glucitol | N-butyl-deoxygalactonojirimycin | N-butyldeoxynojirimycin | NB-DNJ | zavesca
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:875766-12-4
0